Health Canada drug identification number

DIN 02241751 — CEREZYME 400 UNIT

CEREZYME is a powder for solution of Imiglucerase marketed by SANOFI-AVENTIS CANADA INC. The full Imiglucerase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02241751
Brand name
CEREZYME
Active ingredient
Imiglucerase
Strength
400 UNIT
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
SANOFI-AVENTIS CANADA INC
Health Canada status
MARKETED
Drug class
Enzyme replacement therapy (recombinant glucocerebrosidase)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.